Clinical Trial Update: Renal PRotection Against Contrast mEdium-induced nephroPathy in High Risk Patients undErgoing Coronary Angiography [NA]

View source ↗

Summary

The clinical trial evaluating renal protection against contrast medium–induced nephropathy in high-risk patients undergoing coronary angiography has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Nephropathy
• Kidney Injury

Snippet

Sponsor: University Hospital, Angers | Conditions: Renal Insufficiency, Contrast Medium-induced Renal Insufficiency | NA | Status: COMPLETED